• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印迹基因调控蛋白家族兄弟成员(BORIS)抑制结直肠癌细胞凋亡。

Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer.

机构信息

Center for Molecular Medicine, Zhejiang Academy of Medical Science, Hangzhou, Zhejiang Province, 310012, P.R. China.

出版信息

Sci Rep. 2017 Jan 18;7:40786. doi: 10.1038/srep40786.

DOI:10.1038/srep40786
PMID:28098226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5241680/
Abstract

Identifying oncogenes that promote cancer cell proliferation or survival is critical for treatment of colorectal cancer. The Brother of Regulator of Imprinted Sites (BORIS) is frequently expressed in most types of cancer, but rarely in normal tissues. Aberrantly expressed BORIS relates to colorectal cancer, but its function in colorectal cancer cells remains unclear. In addition, previous studies indicated the significance of cytoplasm-localized BORIS in cancer cells. However, none of them investigated its function. Herein, we investigated the functions of BORIS in cancer cell proliferation and apoptosis and the role of cytoplasm-localized BORIS in colorectal cancer. BORIS expression correlated with colorectal cancer proliferation. BORIS overexpression promoted colorectal cancer cell growth, whereas BORIS knockdown suppressed cell proliferation. Sensitivity of colorectal cancer cells to 5-fluorouracil (5-FU) was inversely correlated with BORIS expression. These data suggest that BORIS functions as an oncogene in colorectal cancer. BORIS silencing induced reactive oxygen species (ROS) production and apoptosis, whereas BORIS supplementation inhibited apoptosis induced by BORIS short interfering RNA (siRNA), hydrogen peroxide (HO) or 5-FU. Introduction of BORIS-ZFdel showed that cytoplasmic localization of BORIS inhibited apoptosis but not ROS production. Our study highlights the anti-apoptotic function of BORIS in colorectal cancer.

摘要

鉴定促进癌细胞增殖或存活的致癌基因对于结直肠癌的治疗至关重要。印迹基因调控因子兄弟(BORIS)在大多数类型的癌症中频繁表达,但在正常组织中很少表达。异常表达的 BORIS 与结直肠癌有关,但它在结直肠癌细胞中的功能尚不清楚。此外,先前的研究表明细胞质定位的 BORIS 在癌细胞中的重要性。然而,它们都没有研究其功能。在此,我们研究了 BORIS 在癌细胞增殖和凋亡中的功能,以及细胞质定位的 BORIS 在结直肠癌中的作用。BORIS 的表达与结直肠癌的增殖相关。BORIS 的过表达促进结直肠癌细胞生长,而 BORIS 的敲低则抑制细胞增殖。结直肠癌细胞对 5-氟尿嘧啶(5-FU)的敏感性与 BORIS 的表达呈负相关。这些数据表明 BORIS 在结直肠癌中作为致癌基因发挥作用。BORIS 沉默诱导活性氧(ROS)的产生和凋亡,而 BORIS 补充则抑制 BORIS 小干扰 RNA(siRNA)、过氧化氢(HO)或 5-FU 诱导的凋亡。BORIS-ZFdel 的引入表明,BORIS 的细胞质定位抑制了凋亡而不抑制 ROS 的产生。我们的研究强调了 BORIS 在结直肠癌中的抗凋亡功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/c95aae844b16/srep40786-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/fd2f9c849887/srep40786-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/da083467fd16/srep40786-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/d2f95902b36d/srep40786-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/423273f9f5c1/srep40786-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/972acf90fff3/srep40786-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/6ca6698606c0/srep40786-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/5703af682049/srep40786-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/c95aae844b16/srep40786-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/fd2f9c849887/srep40786-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/da083467fd16/srep40786-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/d2f95902b36d/srep40786-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/423273f9f5c1/srep40786-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/972acf90fff3/srep40786-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/6ca6698606c0/srep40786-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/5703af682049/srep40786-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb94/5241680/c95aae844b16/srep40786-f8.jpg

相似文献

1
Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer.印迹基因调控蛋白家族兄弟成员(BORIS)抑制结直肠癌细胞凋亡。
Sci Rep. 2017 Jan 18;7:40786. doi: 10.1038/srep40786.
2
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.通过靶向BORIS的小干扰RNA实现乳腺癌细胞的选择性凋亡
Biochem Biophys Res Commun. 2008 May 23;370(1):109-12. doi: 10.1016/j.bbrc.2008.03.040. Epub 2008 Mar 18.
3
Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.正常细胞中CTCF旁系同源转录因子BORIS的条件性表达导致MAGE-A1去甲基化和去抑制,并使其他癌胚基因重新激活。
Cancer Res. 2005 Sep 1;65(17):7751-62. doi: 10.1158/0008-5472.CAN-05-0858.
4
Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastoma.BORIS/CTCFL 的下调导致 MYCN 扩增神经母细胞瘤中 ROS 依赖性细胞衰老和药物敏感性。
FEBS J. 2022 May;289(10):2915-2934. doi: 10.1111/febs.16309. Epub 2021 Dec 8.
5
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.BORIS/CTCFL对上皮癌干细胞干性基因表达、成球能力及细胞存活的不同影响
PLoS One. 2015 Jul 17;10(7):e0132977. doi: 10.1371/journal.pone.0132977. eCollection 2015.
6
Atractyloside mimics knockdown to induce DNA damage in colorectal cancer cells.苍术苷模拟基因敲低以诱导结肠癌细胞中的DNA损伤。
Int J Clin Exp Pathol. 2018 Jul 1;11(7):3286-3293. eCollection 2018.
7
Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.糖酵解对于瞬时受体电位通道 C5 在结直肠癌中诱导的化疗耐药性是必不可少的。
BMC Cancer. 2018 Feb 20;18(1):207. doi: 10.1186/s12885-018-4123-1.
8
The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.位于远端的长链非编码RNA HOXA转录本通过部分沉默p21表达促进结直肠癌生长。
Tumour Biol. 2016 Jun;37(6):7431-40. doi: 10.1007/s13277-015-4617-2. Epub 2015 Dec 17.
9
The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.长链非编码RNA PVT1在结直肠癌肿瘤组织及细胞外囊泡中的表达模式与癌症进展相关。
Tumour Biol. 2017 Apr;39(4):1010428317699122. doi: 10.1177/1010428317699122.
10
The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.癌症睾丸抗原 BORIS 在正常和肿瘤细胞中表型模拟肿瘤抑制因子 CTCF。
Int J Cancer. 2013 Oct 1;133(7):1603-13. doi: 10.1002/ijc.28184. Epub 2013 May 2.

引用本文的文献

1
Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation.白术内酯抑制吉非替尼耐药的非小细胞肺癌细胞增殖。
Oncol Lett. 2024 Jul 30;28(4):466. doi: 10.3892/ol.2024.14599. eCollection 2024 Oct.
2
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.癌睾丸抗原:利用癌症基因组不稳定性的新兴治疗靶点。
Mol Ther Oncol. 2024 Jan 26;32(1):200768. doi: 10.1016/j.omton.2024.200768. eCollection 2024 Mar 21.
3
Synaptopodin-2: a potential tumor suppressor.突触足蛋白-2:一种潜在的肿瘤抑制因子。

本文引用的文献

1
The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements.癌症相关的CTCFL/BORIS蛋白靶向多种类型的基因组重复序列,对类人特异性SVA转座元件具有独特的结合和功能偏好。
Epigenetics Chromatin. 2016 Aug 31;9(1):35. doi: 10.1186/s13072-016-0084-2. eCollection 2016.
2
A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility.BORIS的一个多态性微卫星区域调控基因表达,其罕见变异与肺癌易感性相关。
Exp Mol Med. 2016 Jul 15;48(7):e246. doi: 10.1038/emm.2016.50.
3
Cancer Cell Int. 2023 Aug 7;23(1):158. doi: 10.1186/s12935-023-03013-6.
4
Boris knockout eliminates AOM/DSS-induced in situ colorectal cancer by suppressing DNA damage repair and inflammation.Boris 基因敲除通过抑制 DNA 损伤修复和炎症反应消除 AOM/DSS 诱导的结直肠原位癌。
Cancer Sci. 2023 May;114(5):1972-1985. doi: 10.1111/cas.15732. Epub 2023 Feb 5.
5
BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.BTApep-TAT 肽抑制 BORIS 的 ADP-ribosylation,从而诱导癌症中的 DNA 损伤。
Mol Cancer. 2022 Aug 2;21(1):158. doi: 10.1186/s12943-022-01621-w.
6
3D chromatin architecture and transcription regulation in cancer.癌症中的 3D 染色质结构和转录调控。
J Hematol Oncol. 2022 May 4;15(1):49. doi: 10.1186/s13045-022-01271-x.
7
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.CTCFL 调控 PI3K-Akt 通路,是卵巢癌个体化治疗的靶点。
NPJ Syst Biol Appl. 2022 Feb 7;8(1):5. doi: 10.1038/s41540-022-00214-z.
8
Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model.基于计算机设计的多表位癌症疫苗对 BORIS 癌-睾丸抗原靶点在小鼠乳腺癌模型中的免疫保护作用。
Sci Rep. 2021 Nov 30;11(1):23121. doi: 10.1038/s41598-021-01770-w.
9
Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer.印记位点调节因子的兄弟蛋白抑制非小细胞肺癌中顺铂诱导的DNA损伤。
Oncol Lett. 2020 Nov;20(5):251. doi: 10.3892/ol.2020.12114. Epub 2020 Sep 17.
10
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.BORIS/CTCFL促使黑色素瘤细胞从增殖表型向侵袭表型转变。
Cell Death Discov. 2020 Jan 2;6:1. doi: 10.1038/s41420-019-0235-x. eCollection 2020.
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
印记位点调节因子(BORIS)变异亚家族6的同源物与宫颈癌干性相关,可作为免疫治疗的靶点。
Oncotarget. 2016 Mar 8;7(10):11223-37. doi: 10.18632/oncotarget.7165.
4
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.BCL-2 三十年:将细胞死亡发现转化为新型癌症疗法。
Nat Rev Cancer. 2016 Feb;16(2):99-109. doi: 10.1038/nrc.2015.17.
5
First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405.转移性结直肠癌的一线治疗:解读FIRE-3、PEAK和CALGB/SWOG 80405研究
Curr Treat Options Oncol. 2015 Nov;16(11):52. doi: 10.1007/s11864-015-0369-x.
6
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.BORIS/CTCFL对上皮癌干细胞干性基因表达、成球能力及细胞存活的不同影响
PLoS One. 2015 Jul 17;10(7):e0132977. doi: 10.1371/journal.pone.0132977. eCollection 2015.
7
FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.FOLFOX/FOLFIRI药物遗传学:结直肠癌治疗中对个性化方法的需求。
World J Gastroenterol. 2014 Aug 14;20(30):10316-30. doi: 10.3748/wjg.v20.i30.10316.
8
BORIS/CTCFL is an RNA-binding protein that associates with polysomes.BORIS/CTCFL是一种与多核糖体相关的RNA结合蛋白。
BMC Cell Biol. 2013 Nov 26;14:52. doi: 10.1186/1471-2121-14-52.
9
Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner.高分辨率细胞遗传学分析以患者特异性方式揭示与结直肠癌相关的新基因。
PLoS One. 2013 Oct 30;8(10):e76251. doi: 10.1371/journal.pone.0076251. eCollection 2013.
10
Expression of the cancer-testis antigen BORIS correlates with prostate cancer.BORIS 癌-睾丸抗原的表达与前列腺癌相关。
Prostate. 2014 Feb;74(2):164-76. doi: 10.1002/pros.22738. Epub 2013 Oct 4.